Disclosed positions

Estimated from their latest filings — positions may have changed since

$255.96M

combined est. value

Stock	Shares	Price	Value	Weight	As of
MDGLMADRIGAL PHARMACEUTICALS, INC.	452,704	$565.40	$255.96M	100%	2026-01-26

MDGL

MADRIGAL PHARMACEUTICALS, INC.

$255.96M

452,704 sh

All filings on record

Every Form 4 transaction we track for this filer

all 72buys 0sells 63

Stock	Transaction	Date	~6mo later
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $318.6K · 647 sh	2026-01-26	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $1.10M · 2,238 sh	2026-01-20	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $110.2K · 200 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $21.8K · 40 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Exercise $3.8K · 240 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $217.1K · 400 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $21.6K · 40 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $215.7K · 400 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $21.5K · 40 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $206.7K · 385 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $160.2K · 299 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $47.6K · 89 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $144.8K · 271 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $21.3K · 40 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $15.9K · 30 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $135.8K · 256 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $293.2K · 554 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $245.6K · 465 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $598.1K · 1,135 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $480.3K · 913 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $781.9K · 1,489 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $699.6K · 1,335 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $382.8K · 732 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $306.9K · 588 sh	2026-01-09	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $229.3K · 440 sh	2026-01-09	—

MDGLSell

2026-01-26 · MADRIGAL PHARMACEUTICALS, INC.

$318.6K

—

MDGLSell

2026-01-20 · MADRIGAL PHARMACEUTICALS, INC.

$1.10M

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$110.2K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$21.8K

—

MDGLExercise

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$3.8K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$217.1K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$21.6K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$215.7K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$21.5K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$206.7K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$160.2K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$47.6K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$144.8K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$21.3K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$15.9K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$135.8K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$293.2K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$245.6K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$598.1K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$480.3K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$781.9K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$699.6K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$382.8K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$306.9K

—

MDGLSell

2026-01-09 · MADRIGAL PHARMACEUTICALS, INC.

$229.3K

—

Show all 72 filings

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.